C12N 2780/00011
Details
C12N2780/00011 (Details) appears on 2 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 4
- Assignees
- 6
- Inventors
- 10
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 2 | 0 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2780/00034Use of virus or viral component as vaccineIndexing code1
- C12N 2780/00041Use of virus, viral particle or viral elements as a vectorIndexing code1
- C12N 2780/00071Demonstrated in vivo effectIndexing code1
- C12N 2780/00021Viruses as suchIndexing code0
- C12N 2780/00022New viral proteins or individual genes, new structural or functional aspects ofIndexing code0
- C12N 2780/00023Virus like particles [vlp]Indexing code0
- C12N 2780/00031Uses of virus other than therapeutic or vaccineIndexing code0
- C12N 2780/00032Use of virus as therapeutic agent, other than vaccineIndexing code0
All 13 subgroupsShow fewer
- C12N 2780/00033Use of viral protein as therapeutic agent other than vaccineIndexing code0
- C12N 2780/00051Methods of production or purification of viral materialIndexing code0
- C12N 2780/00061Methods of inactivation or attenuationIndexing code0
- C12N 2780/00088For redistributionIndexing code0
- C12N 2780/10011NarnaviridaeIndexing code0
Recent patents
- Compositions for reprogramming cells into dendritic cells type 2 competent for antigen presentation, methods and uses thereof2 May 2024US 2024/0139239 A1Asgard Therapeutics AB
- Baculovirus expression vector7 Dec 2023US 2023/0390380 A1Intervet Inc.
- Methods and compositions for the expression of constitutively active rap1a from a vmd2 promoter3 Nov 2022US 2022/0347318 A1University of Florida
- Crisprs19 Jul 2018US 2018/0201921 A1Excision Biotherapeutics, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.